On-Demand Webinars

Watch Drs. Tonya Chaffee and Irene Stafford discuss the increasing rate of Sexually Transmitted Infections (STI) in the U.S. population. The following topics will be addressed: the importance of opt-out screening as the most effective strategy to reduce STI prevalence in chlamydia and gonorrhea and real-world data reflective of current clinical practices in the U.S. for Mycoplasma genitalium and ways to improve patient care through established testing guidelines. LEARN ABOUT DR. CHAFFEE AND DR. STAFFORD.

During this presentation, Dr. Erik Munson will discuss Mycoplasma genitalium (M. gen), a prevalent and often misdiagnosed STI, will be discussed. Upon completion of this video, viewers will be able to: Describe M. gen and why it is challenging to diagnose Explain the clinical presentation of M. gen and its associated health consequences Summarize the prevalence of M. gen State the CDC guidelines for M. gen testing Outline the treatment options for M. gen depending on the availability of resistance testing Compare RNA and DNA-based tests for M. gen detection LEARN MORE ABOUT THE SPEAKER

During this presentation, Dr. Erik Munson will discuss Mycoplasma genitalium (M. gen), a prevalent and often misdiagnosed STI, will be discussed. Upon completion of this video, viewers will be able to: Describe M. gen and why it is challenging to diagnose Explain the clinical presentation of M. gen and its associated health consequences Summarize the prevalence of M. gen State the CDC guidelines for M. gen testing Outline the treatment options for M. gen depending on the availability of resistance testing Compare RNA and DNA-based tests for M. gen detection LEARN MORE ABOUT THE SPEAKER

Join Dr. Jamie Shutter and Dr. Melissa Maxwell-Stropes as they discuss the latest CDC recommendations for Mycoplasma genitalium testing and the importance of utilizing rRNA-based NAAT (Nucleic Acid Amplification Testing). LEARN MORE ABOUT THE SPEAKER

From the 2021 World Microbe Forum, join leading medical professionals to discuss detection, prevalence, and treatment of the STI Mycoplasma genitalium (M. gen) from laboratory and clinical perspectives.

  Join Dr. Lisa Manhart, Professor of Epidemiology and Global Health Associate Dean for Research, Dr. William M. Geisler, Professor of Medicine and Epidemiology Co-Director, and Dr. Stephen Jordan, Associate Professor of Medicine, as they discuss the background of Mycoplasma genitalium, the importance of testing with NAAT, the problem of antimicrobial resistance, and more.  

In this webinar, Irene Stafford, MD, Assistant Professor, Division of Maternal Fetal Medicine at the Department of Obstetrics and Gynecology, Baylor College of Medicine, discusses the prevalence of M. genitalium in pregnant women as well as potential health complications for untreated infections. Click below to view the webinar in this window: 

Join Tonya Chaffee, MD, Clinical Professor in the Department of Pediatrics at UCSF, as she reviews prevalence, diagnosis, and consequences of untreated Chlamydia trachomatis and Neisseria gonorrhoeae infections, highlights current screening and testing guidelines, and discusses her own experience with implementation of universal screening in her clinical practice. Click below to view the webinar in this window: 

In this webinar, William M. Geisler MD, MPH, Assistant Professor in the Division of Infectious Diseases at University of Alabama at Birmingham, reviews current limitations to managing and preventing MG infections, prevalence of the infection, and an overview of diagnosis and treatment options. Click below to view the webinar in this window: